COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain.
Narmeen MallahJacobo Pardo-SecoSonia Ares GomezLuis-Ricardo López-PérezJuan-Manuel González-PérezBenigno RosónMaría-Teresa Otero-BarrósCarmen Durán-ParrondoVictoria Nartallo-PenasSusana Mirás-CarballalCarmen Rodríguez-Tenreiro-SánchezIrene Rivero CalleAlberto Gómez-CarballaAntonio SalasFederico M TorresPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2023)
In Galicia, mRNA VE was moderate against SARS-CoV-2 infections in the 5-11-year-old populations, but high in older children. VE declined over time, suggesting a potential need for booster dose schedules.